Delcath Systems (DCTH) Nearly Doubles on FDA Orphan Status Announcement Shares in Delcath Systems (DCTH) nearly doubled Wednesday after the FDA announced that it had granted orphan status to melphalan for treatment of patients with hepatocellular carcinoma (primary 2 MIN READ 10.2.2013